Purpose Chitosan-shelled/decafluoropentane-cored oxygenloaded nanodroplets (OLN) are a new class of nanodevices to effectively deliver anti-cancer drugs to tumoral cells. This study investigated their antitumoral effects 'per se', using a mathematical model validated on experimental data. Methods OLN were prepared and characterized either in vitro or in vivo. TUBO cells, established from a lobular carcinoma of a BALB-neuT mouse, were investigated following 48 h of incubation in the absence/presence of different concentrations of OLN. OLN internalization, cell viability, necrosis, apoptosis, cell cycle and reactive oxygen species (ROS) production were checked as described in the Method section.
INTRODUCTION
Innovative drug delivery nanodevices can improve the pharmacokinetics and biodistribution of chemoterapeutics (1) . Since cells can internalize small materials (2), drug delivery systems at the nanoscale range are expected to provide new interesting therapeutic approaches (3) . Nanoparticle sizes are small enough to allow intra-or trans-capillary passage while surface modification can be tuned to avoid macrophage uptake and to favour the accumulation in specific tissues. Nanoparticles, when properly synthesized from biodegradable materials (4), can be biocompatible and improve the stability of active compounds. Furthermore, they can overcome drug resistance issues by greatly improving drug effectiveness and reducing chances for side effects to arise (1, 5) . Hypoxia-activated, near-infrared (NIR) light-triggered chitosan nanoparticles have been developed to deliver drugs to cancer cells (6) . Recently, a new class of nanodevices for oxygen storage and release has been designed, namely perfluoropentanebased oxygen-loaded nanobubbles and decafluoropentanebased oxygen-loaded nanodroplets (7, 8) . Both nanodevices, coated with biocompatible and biodegradable polysaccharides such as dextran sulfate or chitosan, proved to be effective in oxygen delivery either in vitro or in vivo (7) (8) (9) (10) . Chitosan-shelled/decafluoropentane-cored oxygen-loaded nanodroplets (OLN), having average diameters of about 700 nm, positive charge and long-term stability (7) have been designed as potential therapeutic tools to promote healing processes in infected chronic wounds, since chitosan-based OLN displayed antimicrobial properties against methylcillin-resistant Staphylococcus aureus and Candida albicans (11) . Interestingly, this types of OLN showed the capability to overcome hypoxia-dependent dysregulation of matrix-associated proteolytic enzymes such as matrix metalloproteinases (12) .
In the present study the effects of chitosan-shelled OLN on the growth of TUBO breast cancer cells will be designed either in vitro or in vivo. OLN internalization by TUBO cells was investigated and its effectiveness on cell viability along with some possible underlying mechanisms was assessed with the aim to define the key parameters. For this purpose, a simple mathematical model simulating the OLN uptake by TUBO cells and their cell interactions was developed to describe the crucial role played by nanodroplet internalization on the cell viability.
MATERIALS AND METHODS

Materials
Unless otherwise stated, all materials were from SigmaAldrich (St Louis, MO). Ethanol (96%) was from Carlo Erba (Milan, Italy); Epikuron 200® (soya phosphatidylcholine 95%) was from Degussa (Hamburg, Germany); palmitic acid, decafluoropentane (DFP), chitosan, and polyvinylpyrrolidone (PVP) were from Fluka (Buchs, Switzerland); ultrapure water was obtained using a 1-800 Millipore system (Molsheim, France); Ultra-Turrax SG215 homogenizer was from IKA (Staufen, Germany); PEN-STREP was from Cambrex Bio Science (Vervies, Belgium); LSM710 inverted confocal laser scanning microscope was from Carl Zeiss (Oberkochen, Germany); Synergy HT microplate reader was from Bio-Tek Instruments (Winooski, VT); FACScan flow cytometer and CellQuest software were from Becton & Dickinson (Mountain View, CA); SPSS 16.0 software from SPSS (Chicago, IL, USA). TUBO cells were kindly provided by Dr. Laura Conti, Molecular Biotechnology Center, University of Torino. BALB/c mice were bred under specific pathogen-free conditions (Allentown Caging E q ui p m e n t , A l l e nt o w n , N J ) a t t h e M o l e c u l a r Biotechnology Center and treated according to current European guidelines and policies. The experimental plan was approved by the Bioethical Committee of the University of Torino.
Preparation of FITC-Labeled Chitosan
FITC-labeled chitosan was obtained by the reaction between the isothiocyanate group of FITC and the primary amine group of the d-glucosamine residue of chitosan. For this purpose, one gram of chitosan was dissolved in 100 ml of 0.10 M acetic acid. To the chitosan solution, 100 ml of dehydrated methanol was slowly added with continuous stirring. A FITC methanol solution (2 mg/ml), was slowly added to the chitosan solution. The reaction was allowed to proceed for 3 h in the dark at room temperature. FITC-labeled chitosan was precipitated in 0.1 M sodium hydroxide solution. The precipitate was washed extensively with deionized distilled water, to eliminate free FITC. The labeled polymer was then freeze dried.
Preparation of Chitosan-Shelled/Decafluoropentane-Cored OLN
Chitosan-shelled/decafluoropentane-cored (OLN) were prepared as previously described using a two-step method (7, 8) . At first, a decafluoropentane nanoemulsion was obtained and stabilized with dipalmitoylphosphatidylcholine and palmitic acid (1% w/v). The nanoemulsion was saturated with oxygen, up to a gas concentration of 30 mg/L. Subsequently, a chitosan solution (2.7% w/v) at pH = 5.5 was added dropwise under stirring, maintaining the oxygen purge up to 30 mg/L. Fluorescent-labelled OLN were then prepared with the same preparation protocol above described but using fluorescein isothiocyanate (FITC)-chitosan for the shell.
The two OLN formulations were sterilized through ultraviolet (UV)-C ray exposure for 20 min. To control the sterilization efficacy, UV-C treated OLN were incubated with cell culture DMEM medium in a humidified CO 2 /air incubator at 37°C up to 72 h. No signs of microbial contamination were observed when OLN and FITC-labeled OLN were checked by optical microscopy.
Physico-Chemical Characterization of Chitosan-Shelled/Decafluoropentane-Cored OLN Blank-unlabelled and fluorescent-labelled OLN formulations were in vitro characterized to evaluate size, morphology and surface charge. The average diameter and polydispersity index of the OLN formulations were measured by photocorrelation spectroscopy (PCS) using a 90 Plus instrument (Brookhaven, NY, USA) at a fixed angle of 90°and a temperature of 25°C after dilution with filtered water. Each value represents the average of five measurements of three different sample batches. For zeta potential determination, the diluted OLN formulations were placed in an electrophoretic cell, where a rounded 15 V/cm electric field was applied. Each value reported is the average of ten measurements of three different formulations. The morphology of unlabelled-OLN formulations was determined by transmission electron microscopy (TEM) analysis performed using a Philips CM10 instrument (Eindhoven, NL). Nanodroplet preparations were dropped onto a Formvar-coated copper grid and air-dried prior to examination.
In Vitro Oxygen Release from Chitosan-Shelled/Decafluoropentane-Cored (OLN) I n v i t r o o x y g e n r e l e a s e f r o m c h i t o s a n -s h e l l e d / decafluoropentane-cored OLN was investigated using the dialysis bag technique. The donor phase, consisting of 3 mL of OLN formulation, was placed in a dialysis bag (cellulose membrane, molecular weight of 12-14,000 Da), hermetically sealed and immersed in 45 mL of the receiving phase. The receiving phase consisted of 0.9% (w/v) NaCl (saline) solution whit a oxygen concentration of 4 mg/L. The oxygen concentration was previously reduced with a N 2 purge in order to mimic hypoxic conditions. Then, the oxygen release kinetics from OLN was monitored for 8 h, using an oxymeter (HQ40d model, Hach) at 37°C.
Cell Cultures
TUBO cells, a cloned rat Her2/neu + cell line established from a lobular carcinoma of a BALB-neuT mouse (13) were cultured in high glucose DMEM, containing 20% fetal bovine serum (FBS), 2 mM L-glutamine and 1% penicillinstreptomycin (PEN-STRE TEMP) in a humidified CO 2 /airincubator at 37°C.
Evaluation of OLN Uptake by TUBO Cells
TUBO cells were plated in 6-well plates on glass coverslips and incubated in DMEM medium for 24 h with/without 10% v/v FITC-labelled OLN in a humidified CO 2 /air-incubator at 37°C. The procedure followed is fully described in (8) .
Cell Viability Assay
Cell viability was checked by MTT assay. Cells were seeded at 4 × 10 4 cells/200 μl of medium per well in 96-well plates. Twenty-four hours after plating, cells were left untreated or treated with various doses of OLN (2.5%, 5%, 10%, 20%, 40% v/v) up to 72 h. Thereafter, each well received 5 μl of fresh MTT (5 mg/ml in PBS) followed by incubation for 2 h at 37°C. The supernatant growth medium was removed from the wells and replaced with 100 μl of DMSO to solubilize the dark blue formazan crystals. After 15 min of incubation, the absorbance (OD) of the culture plate was read at a wavelength of 562 nm using a Synergy HT microplate reader. Viability of controls was arbitrary fixed to 100%.
Lactate Dehydrogenase (LDH) Release Measurement
The potential necrotic effect of OLN was measured as the release of lactate dehydrogenase (LDH) from TUBO cells into the extracellular medium. Briefly, TUBO were seeded 1 × 10 6 cells/2 ml of medium per well in 6-well plates. Twenty-four hours after plating, cells were incubated for 48 h in the presence or absence of increasing doses (2.5%, 5%, and 10% v/v) of OLN at 37°C in a 5% CO 2 atmosphere. The measurement procedure is described in details in (8) .
Hypodiploid Peak Evaluation and Cell Cycle Phase Analysis
DNA distribution analysis was performed by flow cytometry. Briefly, TUBO were seeded 1 × 10 6 cells/2 ml of medium per well in 6-well plates. Twenty-four hours after plating, cells were incubated for 48 h with OLN (2.5%, 5%, and 10% v/v). Next, TUBO cells were treated as described in (14) .
Reactive Oxygen Species (ROS) Detection
To evaluate ROS production in OLN treated TUBO cells, ROS-mediated fluorescent activation of the compound 5-(and 6)-carboxy-2′-7′-dichlorofluorescein diacetate (carboxy-H 2 DCFDA; Molecular Probes, Invitrogen) was measured, according to manufacturer's instructions. Briefly, cells were seeded in black 96-well plates at 4 × 10 4 cells/200 μl of medium per well. Twenty-four hours after plating, cells were treated with increasing doses of OLN (2.5%, 5%, and 10% v/v) for 24 h. Then, cells were supplied with carboxy-H 2 DCFDA (10 μM) in phenol red-free DMEM for 1 h, washed and incubated in phenol red-free DMEM without carboxy-H 2 DCFDA. Treatment with H 2 O 2 (100 μM) was used as positive control. ROS generation was measured using a fluorescence plate reader (λ ex = 485 nm, λ em = 535 nm) using a Synergy HT microplate reader. ROS control value was arbitrary fixed to 1. Data are expressed as fold increase compared to untreated control.
In Vivo Experiments
Ten-week-old BALB/c female mice were challenged sub- 
Statistical Analysis
Data from MTT assay, LDH measurement, flow cytometry and ROS evaluation are expressed as the mean ± standard deviation (SD) from three independent experiments analyzed in triplicate. Data from confocal microscopy are representative images from three independent experiments with similar results analyzed in duplicate. Statistical differences among different groups were determined by one-way analysis of variance (ANOVA) using SPSS 16.0 software (SPSS, Chicago, IL, USA). P values (p) less than 0.05 were considered as statistically significant.
Mathematical Model
The simulation of the cellular uptake of nanoparticles has been tackled by Salvati and colleagues (15) Based on experimental results, we hypothesized that:
-OLN are internalized only by a fraction of total TUBO cells (possibly in a dose-dependent manner); -TUBO cells, which do not internalize OLN, duplicate with a rate λ = ln (2)/T which can be deduced by the experimental duplication time T = 36 h. They represent the Vital (V) population. -in the other cell population, OLN, after internalization, interact with some intracellular ROS generating mechanism, which may induce, after a time delay, named t0 and related to the uptake time, some apoptotic phenomena.
Toxicity decays from TOX (possibly dose dependent) to 0 with rate m (possibly related to the growth rate as m = k λ). For t < t0 all cells belong to V and duplicate with rate λ.
-After t0 an Apoptotic (A) population develops constituted by the V cells which are unable to duplicate. However, when t > > t0 the A cells population disappears with a death rate μ.
Both cell populations contribute to the MTT measured at different times:
Equations (1-3) can be solved numerically but some information can be obtained by experimental results In particular, two states of equilibrium are predictable. In the first one, i.e. Table I. TEM image of Blank OLN showed the spherical shape and a well-defined core-shell structure of nanodroplets (Fig. 1) . The physico-chemical characteristics of Fluorescent-labelled OLN did not change.
In Vitro Oxygen Release from Chitosan-Shelled/Decafluoropentane-Cored OLN OLN ability to store and release oxygen was in vitro evaluated. Figure 2 shows the percentage of the oxygen released from OLN in a hypoxic receiving chamber over time up to 8 h. Results are shown as fold change of oxygen released relative to the initial concentration of 30 mg/L of the suspension.
Not burst effect was observed. This behavior proved that oxygen is released by a diffusion mechanism from the internal core of the OLN.
OLN Internalization in TUBO Breast Cancer Cells
To study the ability of TUBO cells to internalize OLN, a confocal analysis was performed. TUBO cells were incubated for 24 h with OLN shelled with FITC-labeled chitosan. After fixation and staining with DAPI, confocal microscopy images showed that florescent-labelled OLN were avidly and fast internalized by TUBO cells (Fig. 3) .
The CLSM analyses demonstrated the OLN internalization of Fluorescent-labelled OLN in TUBO cells.
OLN Inhibit TUBO Cells Cell Growth
In order to evaluate the OLN effects on cell growth, TUBO cells treated with increasing doses (2.5%, 5%, 10%, 20% and 40% v/v) of OLN aqueous nanosuspensions were monitored for 24, 48 and 72 h by MTT assay. OLN treatment reduced the viability of TUBO cells in a concentration-and timedependent manner. Interestingly, no significant inhibition of cell proliferation was observed up to 10%-OLN dose. The highest growth inhibition was reached after 48 h of treatment with 40% v/v of OLN, which induced approximately a 90% reduction in cell viability respect to controls. On the other hand, the incubation with 20% v/v of OLN induced only about 30% of inhibition of cell viability. Based on these results, the doses corresponding to 20% and 40% v/v of OLN were not considered for further experiments.
OLN Promote Apoptosis-but Not Necrosis-Related TUBO Cell Death
The effect on apoptosis and necrosis of increasing doses of OLN (2.5%, 5%, 10% v/v) when incubated for 48 h with TUBO cells were measured as alternative parameters of cell death by LDH assay and flow cytometry, respectively (Fig. 4) . As shown in panel 4A, no differences in the percentage of necrosis between OLN-treated (all doses) and untreated TUBO cells were observed. On the other hand, as shown in panels 4B, OLN promoted cell apoptosis, thus increasing the hypodiploid cell peak, in a dose-dependent manner, with~80% cell apoptosis being detected at the highest dose of OLN.
Evaluation of OLN Effects on TUBO Cell Cycle
OLN effects on cell cycle distribution were investigated by flow cytometry. DNA content was measured in TUBO cells after being left untreated or treated with increasing doses (2.5%, 5%, 10% v/v) of OLN nanosuspension for 48 h. As shown in Fig. 4c , OLN did not cause any differences compared to controls in none of TUBO cell cycle phases (S, G0/ G1, and G2/M).
OLN Induce ROS Generation in a Dose-Dependent Manner
After in vitro treating TUBO cells with increasing doses of OLN nanosuspension (2.5%, 5%, 10% v/v) for 24 h, ROS generation was assessed by measuring the fluorescent activation of carboxy-H 2 DCFDA. As shown in Fig. 4d , OLN enhanced ROS production with respect to untreated cells in a dose-dependent manner, reaching a 40% ROS increase at the highest dose.
Evaluation of OLN Effects on In Vivo TUBO Tumor Growth
An in vivo experiment was carried out to obtain the proof of concept of the OLN activity on mice tumor growth. From the preliminary results it seems that OLN might be able to affect tumor growth.
Indeed, when 10-week-old BALB/c female mice were challenged subcutaneously into the mammary fat pad with TUBO cells without OLN, a progressively growing tumor appeared in all mice.
On the other hand, the results were different with OLN. Also it is necessary to take into account that high variability in tumor growth was observed when TUBO cells were inoculated in the presence of OLN. In two out of five mice TUBO cells did not grow, whereas in other two animals the tumor growth appeared strictly delayed. Only in one case the tumor growth rate was similar to that observed in the control group (Fig. 5) . This is an explorative in vivo experiment and more animals would be necessary to draw a conclusion. These data can be used for the validation of the mathematical model.
Modelling Results
In Vitro Cells Viability In Vivo Cell Viability Figure 7 reports the measurements (mean ± SEM) of the control group (blue line) and of the mice treated with OLN (exp = red points, model simulation = line). It is well evident that, after OLN treatment, the tumor growth is impaired with respect to the control (the red points were below the blue line), and the model (black dotted line) seems able to interpolate the experimental data using the parameter values validated on the in vitro model (and not fitting values selected ad hoc). The passage from diameter (mm) to number of cells was performed according to the assumption that 1 mm^3 = 10^6 cells.
Starting from the value estimated from the control group (λ = 0.0096 1/h), simulations were performed using the same values for k, μ and TOX (20 μM) used for the in vitro model.
Taking into account the tumor growth it is always reduced by OLN: it has been significantly slowed in two mice and completely stopped in other two mice. The curve predicted by the numerical simulation, which assumes the same parameter values of the in-vitro model, fits well with the experimental results and could easily be applied to reproduce each experimental dataset by properly adapting the parameter values.
DISCUSSION
Much research has led to the development of nanodevices with antitumor effects and/or capability to selectively deliver drugs to targeted tissues, thus reducing side effects and improve drug effectiveness (18) . The design of nanostructures able to overcome the biological barriers and to affect the uptake within cells have been deeply investigated (19) . The in vivo nanoparticle fate mainly depends on the morphology, size, surface charge and chemical composition; it might be described using similar models, helpful tool to study and to optimize promising nanoplatforms for drug delivery.
Here, chitosan shelled OLN were selected as model nanocarrier for the design of a model useful for predictive information on nanoparticle uptake behaviour. Chitosan, a positively charged natural polymer (20, 21) , showed interesting physical and biological properties for the preparation of drug delivery systems. Moreover, the cytotoxicity of chitosan and its derivatives toward tumor cells has been reported by several authors (22) (23) (24) (25) (26) (27) (28) . Interestingly, cationic chitosan nanoparticles have been already exploited as effective nanocarriers due to their ability to be easily internalized by different cell types (29) (30) (31) . Previously, our group prepared 5-fluorouracil-loaded chitosan nanoparticles, able to increase the cytotoxicity of the drug in vitro (31) . OLN, comprising 2H,3Hdecafluoropentane core, represent an innovative nanodevice developed using chitosan as shell component. As the present study shows, OLN were significantly internalized in vitro by TUBO breast cancer cells, inducing a high cytotoxic activity on this cell line. The OLN uptake by tumor cells can be described as a twostep process, comprising firstly their binding on the cell membrane by electrostatic interactions (32) and their subsequent internalization. As previously demonstrated, the larger the zeta potential of the nanoparticles, the stronger the interactions with tumor cell membrane, favouring the internalization and leading to more severe cytotoxicity. The cationic chitosan can remarkably affects the cell uptake since the positively charged amino groups of chitosan can establish electrostatic interactions with the negatively charged groups exposed on the membrane of tumor cells (33) . Therefore, the high surface charge of about 45 mV of OLN might appear a likely cause for their cytotoxic activity. Several studies have demonstrated that chitosan can induce cell death by promoting necrosis (22, 23) or by inducing apoptosis (27, 28 ) depending on cancer cell type. Cells undergoing apoptosis express cell surface molecules which promote their removal by neighbouring phagocytes. On the other hand, necrotic cells are not generally removed as intact cells and their degradation often causes inflammation (34) . OLN appear to exert per se a cytotoxic activity on TUBO cells in vitro by inducing apoptosis, but not necrosis, mediated cell death. They are, therefore, likely to avoid the triggering of the inflammatory responses.
OLN did not affect the cell cycle kinetics of TUBO cells. However, OLN induced an increase of ROS levels. Various studies showed that ROS can be produced in different cell compartments and are able to damage by oxidation proteins, lipids and DNA (35, 36) . Nanoparticles can induce physico-chemical oxidative stress in mammalian cells by unbalancing the cellular ROS production over the cellular antioxidant defenses through mechanisms still not completely known.
The critical role of ROS in nanoparticle-mediated cytotoxicity and genotoxicity has been reported by several researchers (37) (38) (39) (40) (41) . The molecular oxygen content of OLN did not produce singlet oxygen. The oxidation capability of OLN was evaluated using a lipo-peroxidation assay on linolenic acid, incorporated in liposomes to mimic the membrane phospholipid bilayer. After the exposure to OLN the linolenic acid did not underwent to lipid peroxidation. Indeed, the oxygen loaded within OLN was not able to induce a direct lipoperoxidation (data not shown). These results are in line with the previous data reported by Magnetto et al. (7) .
The oxygen content of the OLN might affect apoptotic effect with a different mechanism.
A hypothesis to explain oxygen toxicity might be related to the partial pressure increase of oxygen inside the tumor cells (42) .
As a matter of fact, oxygen toxicity was detected in case of hyperoxia (e.g. larger fraction of inspired oxygen) at atmospheric pressure or in hyperbaric conditions. The slow diffusion of oxygen from the OLN, together with its low solubility in the intracellular fluid both in-vitro and in-vivo prevents any even transitory condition of hyperoxia.
More than oxygen itself, the interaction of the internalized OLN within the cells may affect mitochondrial respiration, alter the endoplasmatic reticulum activity and also the plasma membrane with its enzyme complexes, including NADPH oxidases or finally activate immune cells. All the above mechanisms can lead to the production of free radicals and be therefore responsible for the toxic effects.
Based on these results OLN might be considered an adjuvant for combination therapy.
The proposed mathematical model, which accounts for the internalization of OLN into the TUBO cells and the subsequent induction of toxicity, satisfactorily explain the experimental in vitro and in vivo results and shows once again that a nanoparticle effective uptake from cells plays a crucial role and should be promoted or enhanced in vivo by proper targeting approaches.
CONCLUSIONS
In this study we validate a computational models predicting the effects of OLN on the in vitro and in vivo growth of TUBO breast cancer cells after investigating OLN cellular internalization, cytotoxicity, antitumor efficacy, and the underlying biological mechanisms. Such a model may have many useful applications, since in the last years nanotechnology formulations have been extensively explored looking forward new possible treatments for several diseases, including cancer.
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